Skip to content
← All settings

DISEASE & TREATMENT SETTING

Malignant Bone Neoplasm

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Malignant Bone Neoplasm

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Added because the terminology and the registry both attest it: an NCIt neoplasm concept named by 1 acquired study condition(s). It is absent from the NCI treatment-topic directory, which is not an exhaustive cancer inventory.
      source wording
      Source null

      Study evidence for this setting

      7 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00869206 · Source cited / selected · Scope: narrower

      Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement

      6 outcome links · 2 safety-group records · 1 quality-of-life measures

      →

      NCT01231906 · Source cited / selected · Scope: narrower

      Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

      6 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT01553539 · Registry condition search · Scope: narrower

      Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery

      5 outcome links · 1 safety-group records · 1 quality-of-life measures

      →

      NCT02306161 · Source cited / selected · Scope: narrower

      Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

      6 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT02516423 · Registry condition search · Scope: narrower

      Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone

      2 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT02609828 · Registry condition search · Scope: narrower

      Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy

      6 outcome links · 4 safety-group records · 0 quality-of-life measures

      →

      NCT03749460 · Registry condition search · Scope: narrower

      Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-malignant-bone-neoplasm
        binding id
        ncit-C4016
        source collection
        ncit-concept
        source key
        C4016
        source excerpt
        Source null
        match status
        exact
        match note
        Source null
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice